nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—AGTR1—ACE Inhibitor Pathway—CMA1—atopic dermatitis	0.00785	0.107	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—FOXP3—atopic dermatitis	0.00212	0.0289	CbGpPWpGaD
Olmesartan—AGTR1—Peptide GPCRs—CCR3—atopic dermatitis	0.00197	0.0269	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL13—atopic dermatitis	0.00181	0.0247	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00177	0.024	CbGpPWpGaD
Olmesartan—AGTR1—Peptide GPCRs—CXCR3—atopic dermatitis	0.00172	0.0235	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL17A—atopic dermatitis	0.00167	0.0227	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00157	0.0214	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL5—atopic dermatitis	0.00155	0.0211	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00141	0.0192	CbGpPWpGaD
Olmesartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.0012	0.0164	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00118	0.0161	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00114	0.0155	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL10—atopic dermatitis	0.00113	0.0154	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL4—atopic dermatitis	0.0011	0.015	CbGpPWpGaD
Olmesartan—AGTR1—Peptide GPCRs—CCR5—atopic dermatitis	0.00108	0.0147	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00106	0.0144	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000947	0.0129	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000945	0.0129	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000927	0.0126	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL22—atopic dermatitis	0.000902	0.0123	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000837	0.0114	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—NPS—atopic dermatitis	0.000837	0.0114	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000827	0.0113	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000827	0.0113	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000811	0.011	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL27—atopic dermatitis	0.000804	0.0109	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK8—atopic dermatitis	0.000786	0.0107	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CASP8—atopic dermatitis	0.000784	0.0107	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000763	0.0104	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000749	0.0102	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000749	0.0102	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000726	0.00989	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL17—atopic dermatitis	0.000721	0.00982	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000683	0.0093	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000676	0.00921	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IFNG—atopic dermatitis	0.000667	0.00908	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000655	0.00892	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000635	0.00865	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000635	0.00864	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—atopic dermatitis	0.000622	0.00847	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000622	0.00847	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CXCL8—atopic dermatitis	0.00062	0.00844	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL1B—atopic dermatitis	0.000595	0.0081	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL2—atopic dermatitis	0.000592	0.00807	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL11—atopic dermatitis	0.000581	0.00791	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000564	0.00768	CbGpPWpGaD
Olmesartan—Dizziness—Tacrolimus—atopic dermatitis	0.000555	0.000599	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000554	0.00755	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000554	0.00755	CbGpPWpGaD
Olmesartan—Discomfort—Prednisolone—atopic dermatitis	0.000553	0.000596	CcSEcCtD
Olmesartan—Angioedema—Triamcinolone—atopic dermatitis	0.000552	0.000596	CcSEcCtD
Olmesartan—Angioedema—Methylprednisolone—atopic dermatitis	0.000551	0.000594	CcSEcCtD
Olmesartan—Myalgia—Hydrocortisone—atopic dermatitis	0.000546	0.00059	CcSEcCtD
Olmesartan—Malaise—Triamcinolone—atopic dermatitis	0.000545	0.000588	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000545	0.00742	CbGpPWpGaD
Olmesartan—Anxiety—Hydrocortisone—atopic dermatitis	0.000544	0.000588	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000544	0.00741	CbGpPWpGaD
Olmesartan—Malaise—Methylprednisolone—atopic dermatitis	0.000544	0.000587	CcSEcCtD
Olmesartan—Vertigo—Triamcinolone—atopic dermatitis	0.000543	0.000586	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000542	0.000585	CcSEcCtD
Olmesartan—Syncope—Triamcinolone—atopic dermatitis	0.000542	0.000585	CcSEcCtD
Olmesartan—Vertigo—Methylprednisolone—atopic dermatitis	0.000542	0.000585	CcSEcCtD
Olmesartan—Syncope—Methylprednisolone—atopic dermatitis	0.000541	0.000583	CcSEcCtD
Olmesartan—Discomfort—Hydrocortisone—atopic dermatitis	0.00054	0.000582	CcSEcCtD
Olmesartan—Connective tissue disorder—Prednisone—atopic dermatitis	0.000539	0.000582	CcSEcCtD
Olmesartan—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000536	0.000579	CcSEcCtD
Olmesartan—Oedema—Prednisolone—atopic dermatitis	0.000536	0.000579	CcSEcCtD
Olmesartan—Vomiting—Tacrolimus—atopic dermatitis	0.000534	0.000576	CcSEcCtD
Olmesartan—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000531	0.000573	CcSEcCtD
Olmesartan—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.00053	0.000572	CcSEcCtD
Olmesartan—Rash—Tacrolimus—atopic dermatitis	0.000529	0.000571	CcSEcCtD
Olmesartan—Dermatitis—Tacrolimus—atopic dermatitis	0.000529	0.000571	CcSEcCtD
Olmesartan—Shock—Prednisolone—atopic dermatitis	0.000528	0.000569	CcSEcCtD
Olmesartan—Cough—Triamcinolone—atopic dermatitis	0.000527	0.000569	CcSEcCtD
Olmesartan—Headache—Tacrolimus—atopic dermatitis	0.000526	0.000568	CcSEcCtD
Olmesartan—Oedema—Hydrocortisone—atopic dermatitis	0.000524	0.000565	CcSEcCtD
Olmesartan—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000524	0.000565	CcSEcCtD
Olmesartan—Tachycardia—Prednisolone—atopic dermatitis	0.000523	0.000565	CcSEcCtD
Olmesartan—Infection—Hydrocortisone—atopic dermatitis	0.00052	0.000561	CcSEcCtD
Olmesartan—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000518	0.000559	CcSEcCtD
Olmesartan—Shock—Hydrocortisone—atopic dermatitis	0.000515	0.000556	CcSEcCtD
Olmesartan—Myalgia—Triamcinolone—atopic dermatitis	0.000514	0.000555	CcSEcCtD
Olmesartan—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000514	0.000554	CcSEcCtD
Olmesartan—Arthralgia—Methylprednisolone—atopic dermatitis	0.000513	0.000554	CcSEcCtD
Olmesartan—Myalgia—Methylprednisolone—atopic dermatitis	0.000513	0.000554	CcSEcCtD
Olmesartan—Anxiety—Methylprednisolone—atopic dermatitis	0.000511	0.000552	CcSEcCtD
Olmesartan—Tachycardia—Hydrocortisone—atopic dermatitis	0.000511	0.000552	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.00051	0.00055	CcSEcCtD
Olmesartan—Skin disorder—Hydrocortisone—atopic dermatitis	0.000509	0.000549	CcSEcCtD
Olmesartan—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000509	0.000549	CcSEcCtD
Olmesartan—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000509	0.000549	CcSEcCtD
Olmesartan—Discomfort—Triamcinolone—atopic dermatitis	0.000508	0.000548	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000508	0.00692	CbGpPWpGaD
Olmesartan—Discomfort—Methylprednisolone—atopic dermatitis	0.000507	0.000547	CcSEcCtD
Olmesartan—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000506	0.000546	CcSEcCtD
Olmesartan—Angioedema—Dexamethasone—atopic dermatitis	0.000501	0.000541	CcSEcCtD
Olmesartan—Angioedema—Betamethasone—atopic dermatitis	0.000501	0.000541	CcSEcCtD
Olmesartan—Anorexia—Hydrocortisone—atopic dermatitis	0.000499	0.000539	CcSEcCtD
Olmesartan—Nausea—Tacrolimus—atopic dermatitis	0.000499	0.000538	CcSEcCtD
Olmesartan—Angiopathy—Prednisone—atopic dermatitis	0.000498	0.000537	CcSEcCtD
Olmesartan—Malaise—Betamethasone—atopic dermatitis	0.000494	0.000534	CcSEcCtD
Olmesartan—Malaise—Dexamethasone—atopic dermatitis	0.000494	0.000534	CcSEcCtD
Olmesartan—Oedema—Triamcinolone—atopic dermatitis	0.000493	0.000532	CcSEcCtD
Olmesartan—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000493	0.000532	CcSEcCtD
Olmesartan—Vertigo—Betamethasone—atopic dermatitis	0.000493	0.000532	CcSEcCtD
Olmesartan—Vertigo—Dexamethasone—atopic dermatitis	0.000493	0.000532	CcSEcCtD
Olmesartan—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000492	0.000531	CcSEcCtD
Olmesartan—Syncope—Betamethasone—atopic dermatitis	0.000492	0.000531	CcSEcCtD
Olmesartan—Syncope—Dexamethasone—atopic dermatitis	0.000492	0.000531	CcSEcCtD
Olmesartan—Arrhythmia—Prednisone—atopic dermatitis	0.00049	0.000529	CcSEcCtD
Olmesartan—Infection—Triamcinolone—atopic dermatitis	0.00049	0.000529	CcSEcCtD
Olmesartan—Hypotension—Hydrocortisone—atopic dermatitis	0.000489	0.000528	CcSEcCtD
Olmesartan—Infection—Methylprednisolone—atopic dermatitis	0.000489	0.000527	CcSEcCtD
Olmesartan—Shock—Triamcinolone—atopic dermatitis	0.000485	0.000524	CcSEcCtD
Olmesartan—Insomnia—Prednisolone—atopic dermatitis	0.000485	0.000523	CcSEcCtD
Olmesartan—Alopecia—Prednisone—atopic dermatitis	0.000485	0.000523	CcSEcCtD
Olmesartan—Shock—Methylprednisolone—atopic dermatitis	0.000484	0.000522	CcSEcCtD
Olmesartan—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000482	0.000521	CcSEcCtD
Olmesartan—Loss of consciousness—Betamethasone—atopic dermatitis	0.000482	0.00052	CcSEcCtD
Olmesartan—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000482	0.00052	CcSEcCtD
Olmesartan—Tachycardia—Triamcinolone—atopic dermatitis	0.000481	0.000519	CcSEcCtD
Olmesartan—Mental disorder—Prednisone—atopic dermatitis	0.00048	0.000519	CcSEcCtD
Olmesartan—Tachycardia—Methylprednisolone—atopic dermatitis	0.00048	0.000518	CcSEcCtD
Olmesartan—Skin disorder—Methylprednisolone—atopic dermatitis	0.000478	0.000516	CcSEcCtD
Olmesartan—Malnutrition—Prednisone—atopic dermatitis	0.000477	0.000515	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000477	0.000515	CcSEcCtD
Olmesartan—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000477	0.000514	CcSEcCtD
Olmesartan—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000476	0.000513	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CCR3—atopic dermatitis	0.000474	0.00645	CbGpPWpGaD
Olmesartan—Insomnia—Hydrocortisone—atopic dermatitis	0.000474	0.000511	CcSEcCtD
Olmesartan—Myalgia—Betamethasone—atopic dermatitis	0.000467	0.000504	CcSEcCtD
Olmesartan—Myalgia—Dexamethasone—atopic dermatitis	0.000467	0.000504	CcSEcCtD
Olmesartan—Anxiety—Betamethasone—atopic dermatitis	0.000465	0.000502	CcSEcCtD
Olmesartan—Anxiety—Dexamethasone—atopic dermatitis	0.000465	0.000502	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—CCL22—atopic dermatitis	0.000463	0.0063	CbGpPWpGaD
Olmesartan—Discomfort—Betamethasone—atopic dermatitis	0.000461	0.000498	CcSEcCtD
Olmesartan—Discomfort—Dexamethasone—atopic dermatitis	0.000461	0.000498	CcSEcCtD
Olmesartan—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000461	0.000497	CcSEcCtD
Olmesartan—Hypotension—Methylprednisolone—atopic dermatitis	0.00046	0.000496	CcSEcCtD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000459	0.00625	CbGpPWpGaD
Olmesartan—Pain—Prednisolone—atopic dermatitis	0.000459	0.000495	CcSEcCtD
Olmesartan—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000455	0.000491	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000454	0.00619	CbGpPWpGaD
Olmesartan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000452	0.000488	CcSEcCtD
Olmesartan—Fatigue—Hydrocortisone—atopic dermatitis	0.000451	0.000487	CcSEcCtD
Olmesartan—Vision blurred—Prednisone—atopic dermatitis	0.00045	0.000486	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000449	0.000485	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000448	0.000484	CcSEcCtD
Olmesartan—Pain—Hydrocortisone—atopic dermatitis	0.000448	0.000483	CcSEcCtD
Olmesartan—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000447	0.000483	CcSEcCtD
Olmesartan—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000447	0.000483	CcSEcCtD
Olmesartan—Oedema—Betamethasone—atopic dermatitis	0.000447	0.000483	CcSEcCtD
Olmesartan—Oedema—Dexamethasone—atopic dermatitis	0.000447	0.000483	CcSEcCtD
Olmesartan—Insomnia—Triamcinolone—atopic dermatitis	0.000446	0.000481	CcSEcCtD
Olmesartan—Insomnia—Methylprednisolone—atopic dermatitis	0.000445	0.00048	CcSEcCtD
Olmesartan—Infection—Betamethasone—atopic dermatitis	0.000444	0.00048	CcSEcCtD
Olmesartan—Infection—Dexamethasone—atopic dermatitis	0.000444	0.00048	CcSEcCtD
Olmesartan—Ill-defined disorder—Prednisone—atopic dermatitis	0.000443	0.000478	CcSEcCtD
Olmesartan—Feeling abnormal—Prednisolone—atopic dermatitis	0.000442	0.000477	CcSEcCtD
Olmesartan—Anaemia—Prednisone—atopic dermatitis	0.000441	0.000476	CcSEcCtD
Olmesartan—Shock—Dexamethasone—atopic dermatitis	0.00044	0.000475	CcSEcCtD
Olmesartan—Shock—Betamethasone—atopic dermatitis	0.00044	0.000475	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000439	0.00599	CbGpPWpGaD
Olmesartan—Nervous system disorder—Betamethasone—atopic dermatitis	0.000439	0.000474	CcSEcCtD
Olmesartan—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000439	0.000474	CcSEcCtD
Olmesartan—Agitation—Prednisone—atopic dermatitis	0.000439	0.000473	CcSEcCtD
Olmesartan—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000438	0.000473	CcSEcCtD
Olmesartan—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000438	0.000473	CcSEcCtD
Olmesartan—Tachycardia—Betamethasone—atopic dermatitis	0.000437	0.000471	CcSEcCtD
Olmesartan—Tachycardia—Dexamethasone—atopic dermatitis	0.000437	0.000471	CcSEcCtD
Olmesartan—Angioedema—Prednisone—atopic dermatitis	0.000436	0.000471	CcSEcCtD
Olmesartan—Dyspepsia—Triamcinolone—atopic dermatitis	0.000434	0.000468	CcSEcCtD
Olmesartan—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000433	0.000467	CcSEcCtD
Olmesartan—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000433	0.000467	CcSEcCtD
Olmesartan—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000433	0.000467	CcSEcCtD
Olmesartan—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000432	0.000466	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—TNF—atopic dermatitis	0.000432	0.00588	CbGpPWpGaD
Olmesartan—Malaise—Prednisone—atopic dermatitis	0.000431	0.000465	CcSEcCtD
Olmesartan—Vertigo—Prednisone—atopic dermatitis	0.000429	0.000463	CcSEcCtD
Olmesartan—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000428	0.000462	CcSEcCtD
Olmesartan—Syncope—Prednisone—atopic dermatitis	0.000428	0.000462	CcSEcCtD
Olmesartan—Anorexia—Betamethasone—atopic dermatitis	0.000426	0.00046	CcSEcCtD
Olmesartan—Anorexia—Dexamethasone—atopic dermatitis	0.000426	0.00046	CcSEcCtD
Olmesartan—Urticaria—Prednisolone—atopic dermatitis	0.000426	0.00046	CcSEcCtD
Olmesartan—Fatigue—Triamcinolone—atopic dermatitis	0.000425	0.000459	CcSEcCtD
Olmesartan—Fatigue—Methylprednisolone—atopic dermatitis	0.000424	0.000458	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—NPS—atopic dermatitis	0.000422	0.00575	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—TAC1—atopic dermatitis	0.000422	0.00575	CbGpPWpGaD
Olmesartan—Pain—Triamcinolone—atopic dermatitis	0.000422	0.000455	CcSEcCtD
Olmesartan—Loss of consciousness—Prednisone—atopic dermatitis	0.00042	0.000453	CcSEcCtD
Olmesartan—Hypotension—Dexamethasone—atopic dermatitis	0.000418	0.000451	CcSEcCtD
Olmesartan—Hypotension—Betamethasone—atopic dermatitis	0.000418	0.000451	CcSEcCtD
Olmesartan—Urticaria—Hydrocortisone—atopic dermatitis	0.000416	0.000449	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000414	0.00564	CbGpPWpGaD
Olmesartan—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000414	0.000447	CcSEcCtD
Olmesartan—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000414	0.000447	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—CCL27—atopic dermatitis	0.000412	0.00562	CbGpPWpGaD
Olmesartan—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000408	0.00044	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000408	0.00044	CcSEcCtD
Olmesartan—Myalgia—Prednisone—atopic dermatitis	0.000406	0.000439	CcSEcCtD
Olmesartan—Arthralgia—Prednisone—atopic dermatitis	0.000406	0.000439	CcSEcCtD
Olmesartan—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000406	0.000439	CcSEcCtD
Olmesartan—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000405	0.000438	CcSEcCtD
Olmesartan—Anxiety—Prednisone—atopic dermatitis	0.000405	0.000437	CcSEcCtD
Olmesartan—Insomnia—Betamethasone—atopic dermatitis	0.000405	0.000437	CcSEcCtD
Olmesartan—Insomnia—Dexamethasone—atopic dermatitis	0.000405	0.000437	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000404	0.000436	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000402	0.000434	CcSEcCtD
Olmesartan—Discomfort—Prednisone—atopic dermatitis	0.000402	0.000433	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000398	0.00542	CbGpPWpGaD
Olmesartan—Dyspepsia—Dexamethasone—atopic dermatitis	0.000394	0.000425	CcSEcCtD
Olmesartan—Dyspepsia—Betamethasone—atopic dermatitis	0.000394	0.000425	CcSEcCtD
Olmesartan—Urticaria—Triamcinolone—atopic dermatitis	0.000392	0.000423	CcSEcCtD
Olmesartan—Urticaria—Methylprednisolone—atopic dermatitis	0.000391	0.000422	CcSEcCtD
Olmesartan—Body temperature increased—Triamcinolone—atopic dermatitis	0.00039	0.000421	CcSEcCtD
Olmesartan—Oedema—Prednisone—atopic dermatitis	0.00039	0.00042	CcSEcCtD
Olmesartan—Anaphylactic shock—Prednisone—atopic dermatitis	0.00039	0.00042	CcSEcCtD
Olmesartan—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000389	0.00042	CcSEcCtD
Olmesartan—Decreased appetite—Betamethasone—atopic dermatitis	0.000389	0.00042	CcSEcCtD
Olmesartan—Decreased appetite—Dexamethasone—atopic dermatitis	0.000389	0.00042	CcSEcCtD
Olmesartan—Infection—Prednisone—atopic dermatitis	0.000387	0.000418	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000386	0.000417	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000386	0.000417	CcSEcCtD
Olmesartan—Fatigue—Dexamethasone—atopic dermatitis	0.000386	0.000416	CcSEcCtD
Olmesartan—Fatigue—Betamethasone—atopic dermatitis	0.000386	0.000416	CcSEcCtD
Olmesartan—Shock—Prednisone—atopic dermatitis	0.000383	0.000414	CcSEcCtD
Olmesartan—Pain—Dexamethasone—atopic dermatitis	0.000383	0.000413	CcSEcCtD
Olmesartan—Pain—Betamethasone—atopic dermatitis	0.000383	0.000413	CcSEcCtD
Olmesartan—Nervous system disorder—Prednisone—atopic dermatitis	0.000382	0.000412	CcSEcCtD
Olmesartan—Tachycardia—Prednisone—atopic dermatitis	0.00038	0.00041	CcSEcCtD
Olmesartan—Skin disorder—Prednisone—atopic dermatitis	0.000378	0.000408	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000378	0.00515	CbGpPWpGaD
Olmesartan—Hyperhidrosis—Prednisone—atopic dermatitis	0.000377	0.000407	CcSEcCtD
Olmesartan—Asthenia—Hydrocortisone—atopic dermatitis	0.000376	0.000405	CcSEcCtD
Olmesartan—Anorexia—Prednisone—atopic dermatitis	0.000371	0.000401	CcSEcCtD
Olmesartan—Pruritus—Hydrocortisone—atopic dermatitis	0.00037	0.0004	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—CCL17—atopic dermatitis	0.00037	0.00504	CbGpPWpGaD
Olmesartan—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000369	0.000398	CcSEcCtD
Olmesartan—Feeling abnormal—Betamethasone—atopic dermatitis	0.000369	0.000398	CcSEcCtD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000366	0.00498	CbGpPWpGaD
Olmesartan—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000366	0.000395	CcSEcCtD
Olmesartan—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000366	0.000395	CcSEcCtD
Olmesartan—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000358	0.000387	CcSEcCtD
Olmesartan—Urticaria—Betamethasone—atopic dermatitis	0.000355	0.000384	CcSEcCtD
Olmesartan—Urticaria—Dexamethasone—atopic dermatitis	0.000355	0.000384	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000355	0.000383	CcSEcCtD
Olmesartan—Dizziness—Prednisolone—atopic dermatitis	0.000355	0.000383	CcSEcCtD
Olmesartan—Asthenia—Triamcinolone—atopic dermatitis	0.000354	0.000382	CcSEcCtD
Olmesartan—Abdominal pain—Dexamethasone—atopic dermatitis	0.000354	0.000382	CcSEcCtD
Olmesartan—Body temperature increased—Betamethasone—atopic dermatitis	0.000354	0.000382	CcSEcCtD
Olmesartan—Body temperature increased—Dexamethasone—atopic dermatitis	0.000354	0.000382	CcSEcCtD
Olmesartan—Abdominal pain—Betamethasone—atopic dermatitis	0.000354	0.000382	CcSEcCtD
Olmesartan—Asthenia—Methylprednisolone—atopic dermatitis	0.000353	0.000381	CcSEcCtD
Olmesartan—Insomnia—Prednisone—atopic dermatitis	0.000352	0.00038	CcSEcCtD
Olmesartan—Pruritus—Triamcinolone—atopic dermatitis	0.000349	0.000376	CcSEcCtD
Olmesartan—Pruritus—Methylprednisolone—atopic dermatitis	0.000348	0.000376	CcSEcCtD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000347	0.00473	CbGpPWpGaD
Olmesartan—Dizziness—Hydrocortisone—atopic dermatitis	0.000346	0.000374	CcSEcCtD
Olmesartan—Dyspepsia—Prednisone—atopic dermatitis	0.000343	0.00037	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000341	0.00464	CbGpPWpGaD
Olmesartan—Decreased appetite—Prednisone—atopic dermatitis	0.000339	0.000366	CcSEcCtD
Olmesartan—Rash—Prednisolone—atopic dermatitis	0.000338	0.000365	CcSEcCtD
Olmesartan—Dermatitis—Prednisolone—atopic dermatitis	0.000338	0.000365	CcSEcCtD
Olmesartan—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000337	0.000363	CcSEcCtD
Olmesartan—Fatigue—Prednisone—atopic dermatitis	0.000336	0.000363	CcSEcCtD
Olmesartan—Headache—Prednisolone—atopic dermatitis	0.000336	0.000363	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000335	0.00456	CbGpPWpGaD
Olmesartan—Constipation—Prednisone—atopic dermatitis	0.000333	0.00036	CcSEcCtD
Olmesartan—Vomiting—Hydrocortisone—atopic dermatitis	0.000333	0.000359	CcSEcCtD
Olmesartan—Rash—Hydrocortisone—atopic dermatitis	0.00033	0.000356	CcSEcCtD
Olmesartan—Dermatitis—Hydrocortisone—atopic dermatitis	0.00033	0.000356	CcSEcCtD
Olmesartan—Headache—Hydrocortisone—atopic dermatitis	0.000328	0.000354	CcSEcCtD
Olmesartan—Dizziness—Triamcinolone—atopic dermatitis	0.000326	0.000352	CcSEcCtD
Olmesartan—Dizziness—Methylprednisolone—atopic dermatitis	0.000325	0.000351	CcSEcCtD
Olmesartan—Feeling abnormal—Prednisone—atopic dermatitis	0.000321	0.000347	CcSEcCtD
Olmesartan—Asthenia—Dexamethasone—atopic dermatitis	0.000321	0.000346	CcSEcCtD
Olmesartan—Asthenia—Betamethasone—atopic dermatitis	0.000321	0.000346	CcSEcCtD
Olmesartan—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000319	0.000344	CcSEcCtD
Olmesartan—Nausea—Prednisolone—atopic dermatitis	0.000318	0.000344	CcSEcCtD
Olmesartan—Pruritus—Dexamethasone—atopic dermatitis	0.000317	0.000342	CcSEcCtD
Olmesartan—Pruritus—Betamethasone—atopic dermatitis	0.000317	0.000342	CcSEcCtD
Olmesartan—Vomiting—Triamcinolone—atopic dermatitis	0.000314	0.000338	CcSEcCtD
Olmesartan—Vomiting—Methylprednisolone—atopic dermatitis	0.000313	0.000338	CcSEcCtD
Olmesartan—Nausea—Hydrocortisone—atopic dermatitis	0.000311	0.000336	CcSEcCtD
Olmesartan—Rash—Triamcinolone—atopic dermatitis	0.000311	0.000336	CcSEcCtD
Olmesartan—Dermatitis—Triamcinolone—atopic dermatitis	0.000311	0.000335	CcSEcCtD
Olmesartan—Rash—Methylprednisolone—atopic dermatitis	0.00031	0.000335	CcSEcCtD
Olmesartan—Dermatitis—Methylprednisolone—atopic dermatitis	0.00031	0.000334	CcSEcCtD
Olmesartan—Urticaria—Prednisone—atopic dermatitis	0.00031	0.000334	CcSEcCtD
Olmesartan—Headache—Triamcinolone—atopic dermatitis	0.000309	0.000333	CcSEcCtD
Olmesartan—Headache—Methylprednisolone—atopic dermatitis	0.000308	0.000333	CcSEcCtD
Olmesartan—Body temperature increased—Prednisone—atopic dermatitis	0.000308	0.000332	CcSEcCtD
Olmesartan—Abdominal pain—Prednisone—atopic dermatitis	0.000308	0.000332	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000307	0.00418	CbGpPWpGaD
Olmesartan—Diarrhoea—Betamethasone—atopic dermatitis	0.000306	0.00033	CcSEcCtD
Olmesartan—Diarrhoea—Dexamethasone—atopic dermatitis	0.000306	0.00033	CcSEcCtD
Olmesartan—AGTR1—Signaling by GPCR—CCL11—atopic dermatitis	0.000298	0.00406	CbGpPWpGaD
Olmesartan—Dizziness—Betamethasone—atopic dermatitis	0.000296	0.000319	CcSEcCtD
Olmesartan—Dizziness—Dexamethasone—atopic dermatitis	0.000296	0.000319	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—FCER2—atopic dermatitis	0.000294	0.00401	CbGpPWpGaD
Olmesartan—Nausea—Triamcinolone—atopic dermatitis	0.000293	0.000316	CcSEcCtD
Olmesartan—Nausea—Methylprednisolone—atopic dermatitis	0.000292	0.000315	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CCL5—atopic dermatitis	0.000288	0.00392	CbGpPWpGaD
Olmesartan—Vomiting—Dexamethasone—atopic dermatitis	0.000284	0.000307	CcSEcCtD
Olmesartan—Vomiting—Betamethasone—atopic dermatitis	0.000284	0.000307	CcSEcCtD
Olmesartan—Rash—Betamethasone—atopic dermatitis	0.000282	0.000304	CcSEcCtD
Olmesartan—Rash—Dexamethasone—atopic dermatitis	0.000282	0.000304	CcSEcCtD
Olmesartan—Dermatitis—Betamethasone—atopic dermatitis	0.000282	0.000304	CcSEcCtD
Olmesartan—Dermatitis—Dexamethasone—atopic dermatitis	0.000282	0.000304	CcSEcCtD
Olmesartan—Headache—Dexamethasone—atopic dermatitis	0.00028	0.000302	CcSEcCtD
Olmesartan—Headache—Betamethasone—atopic dermatitis	0.00028	0.000302	CcSEcCtD
Olmesartan—Asthenia—Prednisone—atopic dermatitis	0.00028	0.000302	CcSEcCtD
Olmesartan—Pruritus—Prednisone—atopic dermatitis	0.000276	0.000297	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—CCL22—atopic dermatitis	0.000273	0.00372	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000268	0.00365	CbGpPWpGaD
Olmesartan—Diarrhoea—Prednisone—atopic dermatitis	0.000267	0.000288	CcSEcCtD
Olmesartan—Nausea—Betamethasone—atopic dermatitis	0.000266	0.000287	CcSEcCtD
Olmesartan—Nausea—Dexamethasone—atopic dermatitis	0.000266	0.000287	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CCR5—atopic dermatitis	0.00026	0.00354	CbGpPWpGaD
Olmesartan—Dizziness—Prednisone—atopic dermatitis	0.000258	0.000278	CcSEcCtD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000248	0.00338	CbGpPWpGaD
Olmesartan—Vomiting—Prednisone—atopic dermatitis	0.000248	0.000267	CcSEcCtD
Olmesartan—Rash—Prednisone—atopic dermatitis	0.000246	0.000265	CcSEcCtD
Olmesartan—Dermatitis—Prednisone—atopic dermatitis	0.000245	0.000265	CcSEcCtD
Olmesartan—Headache—Prednisone—atopic dermatitis	0.000244	0.000263	CcSEcCtD
Olmesartan—AGTR1—Signaling Pathways—CCL27—atopic dermatitis	0.000244	0.00332	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR3—atopic dermatitis	0.000243	0.00331	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GLB1—atopic dermatitis	0.000243	0.0033	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000239	0.00325	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—NPS—atopic dermatitis	0.000239	0.00325	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000234	0.00319	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000233	0.00318	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ADSL—atopic dermatitis	0.000233	0.00317	CbGpPWpGaD
Olmesartan—Nausea—Prednisone—atopic dermatitis	0.000231	0.00025	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—IL5—atopic dermatitis	0.000222	0.00302	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL17—atopic dermatitis	0.000219	0.00298	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TAC1—atopic dermatitis	0.000217	0.00295	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NPS—atopic dermatitis	0.000217	0.00295	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000212	0.00289	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000206	0.00281	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL5—atopic dermatitis	0.000201	0.00274	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KIF3A—atopic dermatitis	0.000195	0.00265	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000189	0.00258	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000177	0.00241	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL11—atopic dermatitis	0.000176	0.0024	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CMA1—atopic dermatitis	0.000176	0.0024	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000172	0.00234	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000168	0.00229	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT6—atopic dermatitis	0.000166	0.00226	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GLB1—atopic dermatitis	0.000163	0.00222	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000163	0.00222	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000157	0.00214	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000156	0.00213	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADSL—atopic dermatitis	0.000156	0.00213	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL5—atopic dermatitis	0.000148	0.00201	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000147	0.002	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR3—atopic dermatitis	0.000144	0.00196	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR5—atopic dermatitis	0.000133	0.00181	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NPS—atopic dermatitis	0.000128	0.00174	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TAC1—atopic dermatitis	0.000128	0.00174	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCR3—atopic dermatitis	0.000126	0.00171	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.00012	0.00164	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL5—atopic dermatitis	0.000119	0.00162	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000119	0.00162	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000113	0.00154	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL10—atopic dermatitis	0.000101	0.00138	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL8—atopic dermatitis	8.87e-05	0.00121	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL5—atopic dermatitis	8.73e-05	0.00119	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2—atopic dermatitis	8.47e-05	0.00115	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NGF—atopic dermatitis	8.09e-05	0.0011	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL8—atopic dermatitis	8.05e-05	0.0011	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARA—atopic dermatitis	7.87e-05	0.00107	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR5—atopic dermatitis	7.87e-05	0.00107	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2—atopic dermatitis	7.7e-05	0.00105	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NFKBIA—atopic dermatitis	6.67e-05	0.000909	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARA—atopic dermatitis	5.29e-05	0.00072	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL8—atopic dermatitis	4.76e-05	0.000648	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2—atopic dermatitis	4.55e-05	0.000619	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—atopic dermatitis	4.52e-05	0.000616	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK8—atopic dermatitis	4.18e-05	0.00057	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—atopic dermatitis	2.67e-05	0.000364	CbGpPWpGaD
